PatientsLikeMe : Methylprednisolone Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.

Patients

Taking Methylprednisolone
204 Patients currently take Methylprednisolone
274 Patients stopped taking Methylprednisolone
Don3567 Sensation: Moderate Overall: Moderate Cognition: moderate Vision: moderate Speech: moderate Swallowing: moderate Upper limb: moderate Walking: moderate See profile Don3567 Solu-Medrol infusion, 1g daily since Jun 14, 2008
pc4069 Sensation: Severe Overall: Mild Cognition: moderate Vision: moderate Speech: none Swallowing: none Upper limb: none Walking: moderate See profile pc4069 Solu-Medrol infusion, 1g monthly since May 28, 2008
capt bubba Sensation: Moderate Overall: Mild Cognition: moderate Vision: moderate Speech: moderate Swallowing: moderate Upper limb: mild Walking: mild See profile capt bubba Solu-Medrol, 1g daily since Oct 06, 2008

Brand Names: Medrol, Medrol DosePak, Solu-Medrol, Solu-Medrol infusion
Generic Name: Methylprednisolone
See also: Methylprednisolone (Infusion)

What is Methylprednisolone? Methylprednisolone is a synthetic corticosteroid drug used primarily as an anti-inflammatory or immunosuppressant agent in the treatment of a variety of diseases including those of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin. Read more...

See more information, including instructions, precautions, side effects, and interactions.

Jump to:: Reasons Taken; Dosages; Duration; Patient Evaluations

Reasons Taken

478 patients in the community are taking or have taken Methylprednisolone.

Reason	# Patients	Percentage of patients
Other	162	33%
Slow my MS progress	146	30%
Stiffness/spasticity	36	7%
Pain	27	5%
disease-related symptoms	19	3%
Fatigue	13	2%
General health	10	2%
Sensation	6	1%
Optic neuritis (inflammation of optic nerve)	6	1%
Support another treatment	5	1%
Numbness, tingling, pins & needles (paresthesia)	5	1%
Balance problems	5	1%
Don't know	5	1%
Excessive daytime sleepiness (somnolence)	4	<1%
Mobility	4	<1%
Vision	4	<1%
Bladder problems	3	<1%
Walking difficulty without aid	2	<1%
Double vision (diplopia)	2	<1%
Heavy sensation in legs	2	<1%
Brain fog	2	<1%
Burning sensation all around torso-like a tight belt	1	<1%
Sensory dysfunction, extreme	1	<1%
Numbness, face	1	<1%
Loss of use of right side	1	<1%
Weakness in legs	1	<1%
Optic Neuritis	1	<1%
Headache	1	<1%
Dizziness	1	<1%
Vision loss	1	<1%
Difficulty walking	1	<1%
Pins and needle in feet & legs	1	<1%
Pain and weakness in hands and arms from the elbows down	1	<1%
Numbness in my hands, arms, legs, and waist	1	<1%
Optic Neuritis, off and on again	1	<1%
Numbness, right foot	1	<1%
Cauda Equina Syndrome (CES) due to MS	1	<1%
Gait	1	<1%
Speech ataxia-problems coordinating speech	1	<1%
Left leg weakness, pain, stiffness	1	<1%
Blurry vision	1	<1%

Dosages

Based on the patients currently taking Methylprednisolone.

Top 10 (Show all)

All (Show Top 10)

0 mg day	0 g month	0 mg month	0 month	0 g none	0 hr none	0 mg none	0 none	0.03333 g month	0.03333 mEq/L month	0.17536 mg year	1 g none	1 g day	1 day	1 g none	2 mg day	4 mg day	4.16625 mg month	7.5 day	8 mg day	10 g day	11.11 mg month	12 mg day	16 mg day	24 mg day	33.33 mg month	40 mg day	50 mg day	71.43 mg week	80 mg day	96 mg day	99.99 mg month	100 mg day	142.86 mg week	250 mg day	333.3 mg month	375 mg none	500 mg day	1000 g day	1000 mg day	2000 mg day
22	1	3	7	10	1	17	12	10	1	1	1	11	1	2	1	2	1	1	2	1	1	1	1	1	13	1	1	1	1	1	1	2	1	1	1	1	4	3	22	1

Duration

How long current patients have been taking Methylprednisolone or how long patients were taking Methylprednisolone before stopping.

Currently taking Methylprednisolone

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
8	14	14	21	24	40

Stopped taking Methylprednisolone

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
172	20	9	16	17	44

Why Patients Stopped Taking Methylprednisolone (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Course of treatment ended	237	86%
Doctor's advice	20	7%
Did not seem to work	18	7%
Side effects too severe	16	6%
Other	12	4%
Not indicated	12	4%

Patient Reported Evaluations

Results from 29 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major	33%	4
Moderate	17%	2
Slight	17%	2
None	8%	1
Can't tell	25%	3

Slow my MS progress

Side-effects (as an overall problem)

Severe	24%	7
Moderate	48%	14
Mild	21%	6
None	7%	2

Top reported side-effects include: Sleeplessness, taste change, Insomnia

Summary results are based on 29 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 29)

Flowers

Sensation: Moderate

Overall: Moderate

Cognition: moderate

Vision: moderate

Speech: moderate

Swallowing: moderate

Upper limb: moderate

Walking: moderate

See profile
by Flowers
Aug 21, 2008

EfficacyMajor
Side-effectsSevere

Slow my MS progress

Advice/Tips: I know alot of people aren't into this treatment, but it's done wonders for me in the past and I will continue with it if I need to.

See full evaluation
0 helpful marks

change

Flare-up: Moderate

Sensation: Moderate

Overall: Moderate

Cognition: moderate

Vision: moderate

Speech: moderate

Swallowing: moderate

Upper limb: moderate

Walking: mild

See profile
by change
Aug 21, 2008